Apalutamide Tablets

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

Four-decade-first: Lok Sabha votes down no-confidence motion against Speaker Om Birla

Representative image illustrating an advanced AI system operating software autonomously, reflecting the Macrohard project unveiled by Tesla, Inc. and xAI, which Elon Musk claims could replicate the full operational functions of software companies using agentic artificial intelligence.

Macrohard : The AI project Musk says no other company can do yet, and what that claim actually means

United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF

Representative image illustrating a drone flying over California as reports reveal that Iran allegedly considered a surprise drone strike on targets in the state, according to a Federal Bureau of Investigation intelligence bulletin disclosed during the ongoing United States–Iran conflict.

Iran planned surprise drone strike on California, FBI bulletin reveals

Zydus Lifesciences enters $1.09bn prostate cancer drug market with USFDA green light

Zydus Lifesciences gains USFDA approval for Apalutamide Tablets, 60 mg, expanding its oncology generics portfolio. Find out what this means for investors.

byPallavi Madhiraju

March 19, 2025

Lupin Limited secures tentative FDA nod for generic Apalutamide Tablets

In a significant stride for global pharmaceuticals, Lupin Limited has garnered tentative approval from the United States Food…

byPallavi Madhiraju

October 13, 2023

The Latest

Four-decade-first: Lok Sabha votes down no-confidence motion against Speaker Om Birla

Macrohard : The AI project Musk says no other company can do yet, and what that claim actually means

United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF

Iran planned surprise drone strike on California, FBI bulletin reveals

Zydus Lifesciences enters $1.09bn prostate cancer drug market with USFDA green light

Lupin Limited secures tentative FDA nod for generic Apalutamide Tablets

Four-decade-first: Lok Sabha votes down no-confidence motion against Speaker Om Birla

Macrohard : The AI project Musk says no other company can do yet, and what that claim actually means

United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF

Iran planned surprise drone strike on California, FBI bulletin reveals

What LG CNS and Palantir’s new partnership means for the future of industrial AI adoption

Trump administration authorises 172 million barrel SPR drawdown as 32 IEA nations coordinate record emergency oil release

The sub-1nm race is heating up and IBM and Lam Research just made their move

Iran: Get ready for $200 oil. IRGC fires on more ships in the Gulf